Literature DB >> 16482509

Binding specificity of Toll-like receptor cytoplasmic domains.

Victoria Brown1, Rachel A Brown, Adrian Ozinsky, Jay R Hesselberth, Stanley Fields.   

Abstract

MyD88 participates in signal transduction by binding to the cytoplasmic Toll/IL-1 receptor (TIR) domains of activated Toll-like receptors (TLR). Yeast two-hybrid experiments reveal that the TIR domains of human TLR differ in their ability to associate with MyD88: The TIR of TLR2 binds to MyD88 but the TIR of the closely related TLR1, 6, or 10 do not. Using chimeric TIR domains, we define the critical region responsible for differential MyD88 binding, and use a computational analysis of the critical region to reveal the amino acids that differ between MyD88 binders and non-binders. Remarkably, a single missense mutation created in TLR1 (N672D) confers on it the ability to bind MyD88, without affecting its association with other proteins. Mutations identified as critical for MyD88 binding also affect signaling of TLR pairs in mammalian cells. To investigate the difference between MyD88 binders and non-binders, we identify novel interacting proteins for each cytoplasmic domain of TLR1, 2, 6, and 10. For example, heat shock protein (HSP)60 binds to TLR1 but not to TLR2, and HSP60 and MyD88 appear to bind the same region of the TIR domain. In summary, interactions between the TLR, MyD88, and novel associated proteins have been characterized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482509      PMCID: PMC2762736          DOI: 10.1002/eji.200535158

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  43 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways.

Authors:  J L Slack; K Schooley; T P Bonnert; J L Mitcham; E E Qwarnstrom; J E Sims; S K Dower
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

3.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

4.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line.

Authors:  Y Nishii; M Morishima; Y Kakehi; K Umehara; N Kioka; Y Terano; T Amachi; K Ueda
Journal:  FEBS Lett       Date:  2000-01-14       Impact factor: 4.124

6.  The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.

Authors:  Annett Schoenemeyer; Betsy J Barnes; Margo E Mancl; Eicke Latz; Nadege Goutagny; Paula M Pitha; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2005-01-28       Impact factor: 5.157

7.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

8.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

9.  Isolation of a 40-kDa Huntingtin-associated protein.

Authors:  M F Peters; C A Ross
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

10.  Drosophila MyD88 is an adapter in the Toll signaling pathway.

Authors:  T Horng; R Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more
  25 in total

1.  Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.

Authors:  Pragnesh Mistry; Michelle H W Laird; Ryan S Schwarz; Shannon Greene; Tristan Dyson; Greg A Snyder; Tsan Sam Xiao; Jay Chauhan; Steven Fletcher; Vladimir Y Toshchakov; Alexander D MacKerell; Stefanie N Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Immune-like phagocyte activity in the social amoeba.

Authors:  Guokai Chen; Olga Zhuchenko; Adam Kuspa
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

3.  Promiscuity is not always bad.

Authors:  Heng Ru; Pengfei Zhang; Hao Wu
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 4.  Innate immune pattern recognition: a cell biological perspective.

Authors:  Sky W Brubaker; Kevin S Bonham; Ivan Zanoni; Jonathan C Kagan
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

5.  Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.

Authors:  Jitendra K Gautam; Laurey D Comeau; Joanna K Krueger; Michael F Smith
Journal:  J Biol Chem       Date:  2006-08-07       Impact factor: 5.157

6.  Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells.

Authors:  Y Lai; J Weng; X Wei; L Qin; P Lai; R Zhao; Z Jiang; B Li; S Lin; S Wang; Q Wu; Z Tang; P Liu; D Pei; Y Yao; X Du; P Li
Journal:  Leukemia       Date:  2017-08-03       Impact factor: 11.528

7.  Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4.

Authors:  Celia Bovijn; Peter Ulrichts; Anne-Sophie De Smet; Dominiek Catteeuw; Rudi Beyaert; Jan Tavernier; Frank Peelman
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

8.  A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction.

Authors:  Kevin S Bonham; Megan H Orzalli; Kachiko Hayashi; Amaya I Wolf; Christoph Glanemann; Wolfgang Weninger; Akiko Iwasaki; David M Knipe; Jonathan C Kagan
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

Review 9.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

10.  Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells.

Authors:  Tadashi Ohara; Yuhsaku Kanoh; Keiichi Yoshino; Masaki Kitajima
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.